Citation notice #8482 · 2026-08-05 06:18:32.709950+00:00
The SChISM study: Cell-free DNA size profiles as predictors of progression in advanced carcinoma treated with immune-checkpoint inhibitors
Correction
Crossref
Open
cites iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics, which carries a correction notice dated 2019-04-30. One-hop deterministic notice: the citation edge exists in the Pith bibliography graph; no model judged whether the citation was load-bearing.
Citing paper Event page Original DOI Notice DOI File a formal challenge All reference changes
01Evidence
Raw extraction · bibliography line · bibliography index 3
Seymour L, Bogaerts J, Perrone A, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol . 2017;18(3):e143 -e152. doi:10.1016/S1470-2045(17)30074-8
02Event
- Type
- Correction
- Source
- Crossref
- Original DOI
- 10.1016/s1470-2045(17)30074-8
- Notice DOI
- 10.1016/s1470-2045(19)30240-2
- Date
- 2019-04-30
- Title
- Correction to Lancet Oncol 2017; 18: e143–52
- Reasons
- ['Erratum']
- Work
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics (2017) 地学教育と科学運動
03Dispute this notice
If this citation does not depend on the flagged claim, or the event is wrong, say so. Disputes are public. For a signed challenge against the paper itself, use the formal challenge form.